Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
A. Menarini Diagnostics is the diagnostics division of Menarini Group, commercially marketing a broad portfolio of in vitro diagnostic systems and reagents for diabetes care, core laboratory testing, urinalysis, immunology, hematology, cell pathology and advanced diagnostics; it does not develop therapeutic drugs but commercializes CE‑marked and FDA‑cleared diagnostic products such as blood glucose systems, HbA1c analyzers, urine analyzers, COVID-19 tests and liquid biopsy/rare cell analysis solutions through Menarini Silicon Biosystems.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on A. Menarini Diagnostics.